First Bite Syndrome After Bilateral Temporomandibular Joint Replacement: Case Report

Alwanni, Nada; Altay, Mehmet Ali; Baur, Dale A.; Quereshy, Faisal A.

doi:10.1016/j.joms.2015.09.034

Cited by 12 publications

(9 citation statements)

References 34 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…A review of the literature reveals multiple descriptions of FBS occurring as a complication of surgical procedures, including dissection of the DLP, 2,8 dissection of the PPS, 9,10 carotid endarterectomy, 5,11 and other surgery of the upper cervical region. 3,12-16 Although postoperative FBS represents more than 95% of the cases published, 4 FBS due to tumor 17,18 and FBS of unknown etiology 1,19 have also been described. Previously cited risk factors include injury to the superior cervical ganglion and ligation or resection of part of the ECA causing damage to the surrounding sympathetic plexus.…”

Section: Discussionmentioning

confidence: 99%

First Bite Syndrome After Parotidectomy: A Case Series and Review of Literature

Gill

Goldfarb

et al. 2020

Ear Nose Throat J

View full text Add to dashboard Cite

Introduction: First bite syndrome (FBS) is a rare but potentially debilitating complication observed after surgery involving the upper cervical region. Patients classically complain of severe facial pain in the ipsilateral parotid region with the first few bites of a meal. Objective: The aim of this study is to shed light on the incidence and potential risk factors of FBS, including a series of cases depicting FBS observed after parotidectomy. Methods: Retrospective review of 419 patients who underwent parotidectomy at a single tertiary care facility between December 2016 and June 2020. Results: With a mean follow-up time of 16.5 months, 8 (2%) patients were documented to have symptoms of FBS after parotid gland surgery. Six of these patients underwent partial parotidectomy by dissection of the deep lobe of the parotid (DLP). Conclusion: Patients undergoing dissection of the DLP are particularly at risk for the development of FBS. All patients should be appropriately counseled during informed consent discussions, especially in high-risk cases.

show abstract

Section: Discussionmentioning

confidence: 99%

First Bite Syndrome After Parotidectomy: A Case Series and Review of Literature

Gill

Goldfarb

et al. 2020

Ear Nose Throat J

View full text Add to dashboard Cite

show abstract

“…Aside from parotid surgery alone, reports of FBS have been related to a variety of upper cervical surgeries, to include procedures in the infratemporal fossa and parapharyngeal space, carotid endarterectomy, and temporomandibular joint replacement. 13,18-22 It has also been encountered after non-invasive treatments including chemotherapy and radiotherapy. 23-24 Some have reported FBS developing in the absence of any inciting factor or history of head and neck surgery.…”

Section: Discussionmentioning

confidence: 99%

First Bite Syndrome Following Rhytidectomy: A Case Report

Gunter

Llewellyn

Perez

et al. 2020

Ann Otol Rhinol Laryngol

View full text Add to dashboard Cite

Background: First bite syndrome (FBS) is a known complication of parotid gland resection, parapharyngeal space dissection, and cervical sympathetic chain injury. It can be described as severe cramping or spasms in the parotid region triggered by the first bite of a meal, with the pain lessening during each subsequent bite. Although dissection for a rhytidectomy is in the vicinity of the parotid parenchyma, face-lift is not typically characterized as a procedure that can lead to FBS. Case description: A 53-year-old female underwent a deep plane face-lift to address her goals of improving jowls, nasolabial folds, and cervicomental angle. Intraoperatively, the dissection proceeded without any complications. Initially, her postoperative course was uneventful; 3 weeks after surgery, she noticed pain at the start of mastication that would improve throughout the course of a meal. She elected to proceed with observation. At 6 months after surgery, she began to experience improvement in her symptoms, and shortly thereafter had complete resolution. Discussion: First bite syndrome is a complication associated with deep lobe parotid resection, first described in 1998. The innervation of the parotid gland is complex and includes contributions from the auriculotemporal nerve, the great auricular nerve, and the cervical sympathetic chain. During rhytidectomy, dissection occurs along the parotidomasseteric fascia in order to elevate a flap of the superficial musculoaponeurotic system. Inadvertent injury to the parotid parenchyma can lead to damage to the postganglionic sympathetic fibers innervating the myoepithelial cells. Ultimately, expectant management is the mainstay of treatment and symptoms typically resolve within 6 months to 1 year. Conclusion: First bite syndrome is a complication that can be seen with a variety of facial surgeries. In the case of rhytidectomy, FBS should be considered a potential risk, as dissection into the parenchyma of the parotid gland can result in postoperative autonomic dysfunction.

show abstract

“…Four case reports (of varying methodological quality) reported the successful management of trigeminal trophic syndrome [33], chemotherapy-induced painful glossopharyngeal neuropathy [34] or first-bite syndrome secondary to schwannoma surgery [35] or to bilateral total temporomandibular joint replacement [36] with pregabalin or gabapentin.…”

Section: Neuropathic Pain à Other Painful Neuropathiesmentioning

confidence: 99%

Gabapentinoid prescription in Oral Medicine and Oral Surgery practice. Part II − a systematic scoping review of the literature

Sulukdjian

L'Homme

Chanlon

et al. 2020

J Oral Med Oral Surg

View full text Add to dashboard Cite

Introduction: Gabapentinoids, pregabalin and gabapentin, neuronal voltage-gated calcium channel inhibitors are first-line treatments for painful neuropathic conditions (and several non-neuropathic painful conditions). Nevertheless, their efficacy and prescription in Oral Medicine and Oral Surgery practice has received little attention so far. A previous article, the first of a two-part series, presented the experience of a French tertiary orofacial pain clinic regarding the prescription of gabapentinoids in orofacial conditions. This second article aimed to explore the scientific literature on the subject. Material and methods: A systematic scoping review was conducted on multiple relevant databases (MEDLINE®, Cochrane®, Agence Nationale de Sécurité du Médicament et des produits de santé, Haute Autorité de Santé) and journal archives (JOMOS, JSOMFS) to assess the indications, non-indications and contraindications of gabapentinoids in an Oral Medicine/Oral Surgery context. Results: Out of 131 records selected during the initial screening, 34 matched the inclusion criteria and were used for subsequent analyses. Gabapentinoids were prescribed in three clinical contexts: orofacial pain management (32 studies), anxiolysis (1 study) and prevention of postoperative nausea/vomiting (1 study), with variable quality of evidence: high (6 studies), moderate (3 studies), low (5 studies) and very low (20 studies) quality studies (GRADE scale). Untoward effects of gabapentinoids were reported in 16 studies, mainly neurological (vertigo, drowsiness, sedation) and gastro-intestinal (nausea, vomiting, diarrhea, constipation). Gabapentinoids were ineffective in preemptive and postoperative analgesia and for the management of mucositis-related pain. Discussion: There is some evidence supporting the use of gabapentinoids in Oral Medicine/Oral Surgery in adherence with current practices observed in France and other countries (practices often extrapolated from their use in other non-orofacial painful conditions). The methodological quality of the studies included in this scoping review is often poor and publication bias is most probable in this field. Therefore, any conclusion drawn from such studies must be subject to circumspection. Conclusion: Data obtained from the present scoping review suggests the potential use of gabapentinoids as second-line treatments for anxiolysis, prevention of postoperative nausea/vomiting and the management of trigeminal neuralgia and masticatory myalgia. Other potential indications of gabapentinoids in Oral Medicine/Oral Surgery practice include cranial neuralgias, post-traumatic trigeminal neuropathies, first bite syndrome, burning mouth syndrome and migraine prophylaxis, when other treatment options are inefficient or unavailable.

show abstract

First Bite Syndrome After Bilateral Temporomandibular Joint Replacement: Case Report

Cited by 12 publications

References 34 publications

First Bite Syndrome After Parotidectomy: A Case Series and Review of Literature

First Bite Syndrome After Parotidectomy: A Case Series and Review of Literature

First Bite Syndrome Following Rhytidectomy: A Case Report

Gabapentinoid prescription in Oral Medicine and Oral Surgery practice. Part II − a systematic scoping review of the literature

Contact Info

Product

Resources

About